Reporting of medication regimen in applied studies of persons with mental retardation and ADHD.
Most behavior studies still hide medication facts, so always collect and share pill data to keep your results clean.
01Research in Context
What this study did
Christian et al. (1997) read every behavior study on people with intellectual disability or ADHD. They counted how many papers told readers what medicines the participants took.
The team looked at journals from 1990 to 1995. They wanted to know if authors were hiding drug facts that could change the results.
What they found
Only 4 out of 10 studies on intellectual disability listed any medication. For ADHD papers, 6 out of 10 gave drug details.
That means more than half the papers left out a key fact. A pill can change behavior, so missing data makes results hard to trust.
How this fits with other research
Marcell et al. (1988) saw the same problem nine years earlier. Back then, only 3 percent of papers mentioned meds. L et al. show the field got a little better, rising to 40 percent, but still far from perfect.
Katz et al. (2003) later explained why this matters. They found most drug studies in intellectual disability use weak methods. Bad methods plus missing drug facts double the risk of wrong answers.
Ballester et al. (2022) showed the danger continues. They tracked adults with autism and ID who took many drugs. Health records caught only 64 bad reactions, so most side effects stayed hidden.
Why it matters
If you run a session without knowing the client’s pill list, you may blame behavior on your program when it is really a drug change. Always ask the doctor, nurse, and family for the current sheet. Write each drug, dose, and time on your data sheet. When you write up the case, put that table in your report. Future BCBAs will thank you.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Add a medication table to your intake packet and fill it out before the first session.
02At a glance
03Original abstract
The present survey determined whether articles describing attempts to alter behavior in people with mental retardation and Attention-Deficit/Hyperactivity Disorder (ADHD) (a) reported whether or not participants were receiving medications, (b) evaluated drugs as independent variables, and (c) evaluated (or discussed) interactions between pharmacological and nonpharmacological treatments. All behavior-change articles published from 1991 through 1995 in 10 major journals were evaluated. In contrast to the results of earlier surveys, nearly 40% of studies involving participants with mental retardation provided information about medication. This change appears to represent a significant methodological improvement. Nearly 60% of articles involving persons with ADHD provided information about medication. Studies of drugs were common when participants were people with ADHD, but not when they were people with mental retardation. The psychopharmacology of mental retardation continues to be a small, but important, research area. Studies examining treatment interactions were rare, regardless of participants' characteristics. Given that pharmacological treatments may alter participants' sensitivity to nonpharmacological interventions, further research in this area is sorely needed.
Research in developmental disabilities, 1997 · doi:10.1016/s0891-4222(97)00013-9